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Genetic screenIn Drosophila, like in humans, Dystrophin Glycoprotein Complex (DGC) deﬁciencies cause a life span
shortening disease, associated with muscle dysfunction. We performed the ﬁrst in vivo genetic interaction
screen in ageing dystrophic muscles and identiﬁed genes that have not been shown before to have a role in
the development of muscular dystrophy and interact with dystrophin and/or dystroglycan. Mutations in
many of the found interacting genes cause age-dependent morphological and heat-induced physiological
defects in muscles, suggesting their importance in the tissue. Majority of them is phylogenetically conserved
and implicated in human disorders, mainly tumors and myopathies. Functionally they can be divided into
three main categories: proteins involved in communication between muscle and neuron, and interestingly, in
mechanical and cellular stress response pathways. Our data show that stress induces muscle degeneration
and accelerates age-dependent muscular dystrophy. Dystrophic muscles are already compromised; and as a
consequence they are less adaptive and more sensitive to energetic stress and to changes in the ambient
temperature. However, only dystroglycan, but not dystrophin deﬁciency causes extreme myodegeneration
induced by energetic stress suggesting that dystroglycan might be a component of the low-energy pathway
and act as a transducer of energetic stress in normal and dystrophic muscles.(H.R. Shcherbata).
-NC-ND license.© 2011 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Stress accelerates ageing and worsens pre-existing health condi-
tions. Different tissues in the organism respond to unfavorable
conditions via various mechanisms and have different thresholds of
how much stress they can resist before damage becomes irreversible.
Muscles are highly sensitive as well as quite resilient to stress and the
signaling pathways involved in adaptive responses in normal muscles
are comprehensively described (Palomero and Jackson, 2010).Normally
muscles canwithstand numerous rough situations induced bymechan-
ical stress; however, dystrophic muscle cells that are present in
Muscular Dystrophy (MD) patients are easily damaged and do not
properly regenerate causing muscle tissue loss. Not only mechanical
stress, but also other environmental stresses may affect muscle tissue
welfare. It is not clear whether dystrophic cells just have an unstable
membrane that is breaking upon stress or the signaling pathways that
are required for proper cell homeostasis are disrupted causing necrotic
processes to overtake the normal muscle regeneration.
Muscle degeneration is a hallmark of Muscular Dystrophies, a
group of genetically inherited fatal diseases that are characterized byconcomitant loss of muscular strength that ultimately leads to skeletal
muscle deterioration and cardiac and/or respiratory failure (Batchelor
and Winder, 2006; Durbeej and Campbell, 2002; Ervasti, 2003). MDs
are mostly related to deﬁciencies in the Dystrophin Glycoprotein
Complex (DGC), a membrane-associated multiprotein complex
classically consisting of dystrophin, the dystroglycans (α and β), the
sarcoglycans (α, β, γ and δ), sarcospan, the syntrophins (α1, β1, β2,
γ1-, γ2) and α-dystrobrevin (Durbeej and Campbell, 2002).
In vertebrates the main component of the complex, Dystrophin
(Dys) is expressed in skeletal and cardiac muscles and brain and
consists of four structural domains, the N-terminal actin-binding
domain, the spectrin-like rod domain, the cystein-rich domain, and
the C-terminus with the Dystroglycan (Dg) interacting WW domain.
Dg is the transmembrane anchor of the complex; it binds to the
extracellular matrix (ECM) component laminin-2 at its N-terminal
end and to the cytoskeleton via Dystrophin at its C-terminal end,
providing a crucial link between the extracellular matrix and
cytoskeletal network (Davies and Nowak, 2006).
In muscles the DGC is best envisioned as a mechanosignaling unit
that has a dual role in muscle membrane stabilization: mechanical via
anchoring the ECM to the cytoskeleton and non-mechanical as a
signal-transducingmodule involved in cross talk between the internal
and external environments of the muscle cell. The binding between
the two main components of the DGC, Dg and Dys is mediated by the
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Dys, and the phosphorylation of Dg might act as a molecular switch
between WW or SH3, and SH2 domains during cellular adhesion in
the process of out–in signaling (Moore and Winder, 2010; Yatsenko
et al., 2009). When Dg interaction with laminin is prevented,
apoptosis is activated and the pro-cell survival signaling, PI3K/AKT
is inhibited (Langenbach and Rando, 2002). Dg is also thought to
modulate the MEK/ERK pathway and c-jun activity (Spence et al.,
2004; Zhou et al., 2007) and recently it has been found in the nucleus
of different cells, suggesting unknown nuclear functions (Fuentes-
Mera et al., 2006).
The DGC helps muscles to withstand the rigors of contraction
(cellular deformation and shortening) that requires the speciﬁc
activity of both the nervous and somatic systems, from excitation of
myoﬁbers at the neuromuscular junction (NMJ) to the ATP-regulated
power-stroke of myosin. The myoﬁber contractile machinery must
remain intimately connected with the sarcolemma and the basement
membrane of the ECM, upon which muscles depend for survival and
function. This interaction is arbitrated primarily by the DGC complex
and integrin receptors. α7 integrin is a muscle-expressed integrin
that, like Dg connects laminin to the cytoskeleton contributing to the
overall integrity of the sarcolemma (Burkin et al., 2001; Cote et al.,
2002). Interestingly, increased amounts of α7 integrin are found in
DMD patients and mdx mice, indicating that enhanced α7 integrin
expression is a mechanism by which muscle can compensate for the
loss of dystrophin, additionally upregulation of integrinα7 in themdx
background can ameliorate some aspects of muscular dystrophy
(Burkin et al., 2001; Cote et al., 2002; Liu et al., 2008). Facts that
integrins can compensate in mediating cell-extracellular matrix
attachment but cannot fully rescue the dystrophic phenotype suggest
that the DGC has additional roles in muscles than just being a
structural link between the cell cytoskeleton and laminin in the basal
lamina.
The DGC also has become known as a scaffold responsible for the
membrane localization of signaling proteins (Pilgram et al., 2010). For
example, neuronal nitric oxide synthase (nNOS) signaling, which
regulates many signaling pathways and is responsible for the direct
regulation of a subset of myo-speciﬁc microRNAs, is coordinated by
the DGC (Adams et al., 2008; Cacchiarelli et al., 2010). Recently
various kinases, channels, and other enzymes have been shown to
associate with the DGC, although only a few of these interactions have
been conﬁrmed in vivo (Adams et al., 2008; Pilgram et al., 2010).
Despite the vast data about the functional diversity of DGC
components, the exact mechanism of how dystrophic muscle cells
degenerate is still elusive. Muscle contraction induces mechanical
stress leading tomuscle injury; however, the specialized repair system
is rapidly activated in healthy muscle, while in dystrophic muscles
necrosis is triggered (Jaalouk and Lammerding, 2009). There are
several potential pathogenic mechanisms implicated in the initiation
ofmuscle decay associatedwith insufﬁciency of the DGC, including the
mechanical fragility of the sarcolemma, high calcium inﬂux, aberrant
cytoskeleton rearrangements, increased energetic stress and abnor-
mal metabolic control and inappropriate cell signalling (Constantin
et al., 2006; Vercherat et al., 2009; Wallace and McNally, 2009).
To address the question on what mechanisms contribute to
dystrophic muscle degeneration we used a previously established
genetically tractable Drosophila MD model (Shcherbata et al., 2007).
First we show that in Drosophila, similarly to human, Dystrophin and
Dystroglycan are localized in striated muscles and required for muscle
maintenance. Second, we carried out the ﬁrst in vivo genetic screen in
themusculature of adult ﬂies exhibitingmuscular dystrophy and found
new genetic components that are involved in the DGC signaling and
regulation. The novelty of this work is that modiﬁers that have been
examined have not been implicated in prior works to have muscle
function and/or interact with the DGC. Third, we established that many
of these genes are required for muscle integrity and physiologicalresponse to heat-induced stress.Most of themhave humanhomologues
that havebeenassociatedwithdifferentdisorders andpotentially canbe
used as easier drug targets for muscular dystrophy treatment. Finally,
we found that unfavorable factors such as high temperature and
oxidative stress cause myodegeneration regardless of the genetic
background; in addition, in dystrophic muscle the damage is signiﬁ-
cantly ampliﬁed in response to low temperature, energetic stress and
ageing. This shows that the adaptive reactions inDys andDgmutants are
somewhat different and suggests that the DGC is not only required for
muscle homeostasis and plasticity, but also plays a role in stress-
response pathways.Dys andDgmutants had rather distinctive response
to different stresses, which shows that they not only act together as
components of one complex, but also might interact with different
partners to ensure proper perpetuation of muscle functioning.
Materials and methods
Fly strains and genetic screen
To identify heterozygous genetic interaction in muscles, loss-of-
functionDysDf,DgO86 (Christoforou et al., 2008) and Dg323 (Deng et al.,
2003) mutant females were crossed to males carrying the mutation of
interest. The progeny heterozygous for Dys or Dg and the screened
allele were collected for muscle analysis. Heterozygotes, in which one
allele of each recessive gene that function in unrelated pathways is
mutant, would show no phenotype. However, if the genes act in the
same pathway, then mutations in two steps should enhance each
other and cause a phenotype. To identify dominant suppressors/
enhancers of the muscle degeneration phenotype, virgin females
DysN-RNAi:act-Gal4 and DgRNAi:tub-Gal4 (Kucherenko et al., 2008) that
have 2.5 and 6 fold mRNA downregulation, respectively (Supplemen-
tary Tables 1, 2) were crossed to males carrying the screened
mutation. Alleles used for the screen were obtained from DGRC and
BDSC. All crosses were kept at 25 °C. Flies with the correct genotype
were aged for three weeks at 25 °C and subsequently analyzed for
muscle degeneration. The data were statistically compared using the
χ2 test and p was calculated based on the critical value.
Other alleles used in this study are:DgO55 (Christoforou et al., 2008),
CG7845EMS-Mod4 (Kucherenko et al., 2008), SP1070Uif-E(br)155 and
SP1070Uif-2B7 (ZhangandWard, 2009), tub-Gal4 andMHC-Gal4 enhancer
trap lines (BDRC), all RNAi lines are from VDRC. For control crosses
either OregonR or w1118 ﬂies were used.
Histology
For analysis of indirect ﬂight muscle (IFM) morphology 10 μm
parafﬁn-embedded sections were cut from ﬂy thoraxes. In order to
prepare Drosophila muscle sections, the ﬂy bodies were immobilized
in collars in the required orientation and ﬁxed in Carnoy ﬁxative
solution (6:3:1=Ethanol:Chloroform:Acetic acid) at 4 °C overnight.
Tissue dehydration and embedding in parafﬁn were performed as
described previously (Kucherenko et al., 2010). Histological sections
were prepared using a HyraxM25 (Zeiss)microtome and stainedwith
hematoxylin and eosin (H&E) or aniline blue (0.12 %). All chemicals
for these procedures were obtained from Sigma Aldrich. Muscle
analysis was done using a light microscope (Zeiss). The frequency of
muscle degeneration was quantiﬁed as a ratio of degeneratedmuscles
to the total number of analyzed muscles. The analyzed IFM sections
were located at a position 200–250 μm to the posterior of the ﬂy
thorax.
To prepare Drosophila muscle cryosections ﬂies were located in
collars and immediately frozen in TissueTek® O.C.T. (Sacura) at about
−40 °C. Frozen muscles were sectioned on a cryo-microtom Leica
CM3050S (between −15 and −18 °C) with a section thickness of
15 μm. Fixationwas carried out in 4% formaldehyde (Polyscience, Inc.)
for 10 min at room temperature.
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(Kucherenko et al., 2010). After tissue ﬁxation, slides were washed
with water twice for 5 min, equilibrated in propylene glycol for
10 min and stained for 3 h in oil red O stain at room temperature.
Samples were washed 2 times for 5 min in propylene glycol and
30 min in 1× PBS. Nuclei were visualized with DAPI. Samples were
mounted in 30% glycerol in 1× PBS.
Immunohistochemistry
Immunostaining was performed according to the previously
described procedures (Shcherbata et al., 2007). After immunostaining
tissue was mounted onto slides in 70% glycerol, 3% NPG, 1xPBS and
analysed using a confocal microscope (Leica TCS SP5). The following
antibodies were used: rabbit anti-Dg (Deng et al., 2003) and anti-Dys
(Schneider et al., 2006) 1:500, rat anti-Kettin (1:200; Babraham
Institute), Alexa 568 goat anti-rabbit, Alexa 488 goat anti-rat (1:500,
Molecular Probes). Nuclei were visualized with DAPI.
Analysis of muscle degeneration in response to stress
Temperature, sugar-free food (energetic stress), Paraquat-containing
food (oxidative stress) and ageing were used as stress conditions. Flies
age and incubation time on stress conditions for different experimental
groups are shown in Supplementary Table 5.
Energetic stress
Allﬂieswere kept on a standard corn-molassesmediumwith yeast,
agar, propionic acid and nipagin. For energetic stress experiments
animals were transferred to plates containing sugar-free food (2.12%
agar–agar in dH2O with 0.2 ml of yeast paste). The control plates
contained medium with 2.12% agar–agar and 2.5% sugar in an apple
juice:dH2O solution (1:3) and0.2 ml of yeast paste (apple juice plates).
Temperature conditions
For temperature condition experiments wild type and mutant ﬂies
hatched at 25 °C, then incubated at 18 °C or 33 °C on apple juice
plates. The control animals were left at 25 °C for the same period of
time.
Oxidative stress
Paraquat (N,N′-dimethyl-4,4′-bipyridinium dichloride) in apple
juicemediumwasused to catalyze the formation of superoxide radicals,
a major form of reactive oxygen species (Bus and Gibson, 1984). Wild
type and mutant ﬂies were hatched in normal food at 25 °C conditions
and transferred as adults to 2.5 mM Paraquat-containing medium. The
control experiment used same age animals on apple juice plates.
Data analysis
The muscle degeneration was counted as the percentage of muscles
with signs of degeneration from total muscle number. Experiments
were repeated at least 2 times for each genotype and 50–200 muscles
were scored in each experiment. The “extreme” muscle degeneration
(EMD, cases where all the muscle was deteriorated or substituted with
non-muscle tissue) was included in percentage of total muscle
degeneration but was treated as a separate group in statistical analysis.
For statistics the One-Way ANOVA with post Dunnett's tests (Version
SPSS 16.0)were used. For analysis ofwild typemuscle response to stress
conditions the data for genotypes (OregonR and w1118) within each
of “experimental conditions” group were compared to each other and
after data were proven not to be different they were treated as an
individual data set. Data from “25 °C and normal food” conditions group
were used as control. For analysis of dystrophic muscles response to
stress conditions the data for genotypes within each of “experimental
conditions” group (DysDf and DgO86/DgO55) were compared to control
(OregonR), and then each genotype from every “experimental condi-tions” group was compared to the respective genotype from control
group (25 °C and normal food). Taking into account the age of animals
used in analysis all experimentswere divided into experimental groups,
which were compared to different controls. In each evaluation the total
muscle degeneration and EMD were compared separately.
Climbing assay
The climbing assay was performed and the climbing index was
calculated as described previously (Shcherbata et al., 2007). The
climbing test was performed 3 times using 20–30 7–10 day old
animals each trial.
Temperature-sensitive activity
Thismethodwas adapted fromMontana and Littleton (2004). Flies
were placed into a preheated vial at a temperature of 39±1 °C.
Temperature-sensitive behavioral defects were scored in 30 s inter-
vals. The analysis was done with at least 5 repetitions for each
genotype and each repetition contained an independent set of 6–18
ﬂies that were 2–5 days old. For the data analysis the mobility index,
which equals the minus logarithm of the absolute value of the slope
(the slope equals change in ordinate divided by change in abscises)
was calculated. The mean value and standard error of 3–5 trials were
calculated and the Student's one-tailed t-test was used.
RNA preparation and real-time PCR
To determine the effect of the Dg RNAi transgene on the Dg
expression levels quantitative reverse transcription (RT-qPCR) was
performed on total RNA derived fromwhole adult animals. RNAswere
extracted from ﬂies with the RNeasy Mini kit (Qiagen), followed by
reverse transcription using the High Capacity cDNA Reverse Tran-
scription kit (Applied Biosystems) following the manufacturer's
protocols. Dg was tested with RpL32 as an endogenous control for
q-PCR using Fast SYBR® Green master mix on a Step One Plus 96 well
system (Applied Systems). The reactions were incubated at 95 °C for
10 min, followed by 40 cycles of 95 °C for 15 s and 54 °C for 30 s. All
reactions were run in triplicate with appropriate blank controls. The
threshold cycle (CT) is deﬁned as the fractional cycle number at which
the ﬂuorescence passes the ﬁxed threshold. Primers were used as
follows: RpL32 forward—AAGATGACCATCCGCCCAGC; RpL32 reverse—
GTCGATACCCTTGGGCTTGC; Dg forward—ACTCAAGGACGAGAAGCCGC;
Dg reverse—ATGGTGGTGGCACATAATCG; Dys forward—GTTGCAGA-
CACTGACCGACG; Dys reverse—CGAGGGCTCTATGTTGGAGC. The ΔCT
value was determined by subtracting the average RpL32 CT value from
the average Dg CT value. The ΔΔCT value was calculated by subtracting
the ΔCT of the control sample (tubGal4/+) from the ΔCT of the suspect
sample (DgRNAi:tubGal4/+). The relative amount of mRNA was then
determined using the expression 2−ΔΔCT. Errors were determined
startingwith the standarddeviation of the rawCT values andperforming
appropriate regression analysis.
Metabolic rates
The production of CO2 is correlated with oxygen consumption and
reﬂects the metabolic rate. The respirometers were 1000 μl micropi-
pette tips with a 50 μl capillary glued to the tip end. A piece of foam
was placed into the pipette to keep ﬂies from falling through to the
end of the tip. Five ﬂies were placed into the container and another
piece of foam was ﬁtted to the top portion of the tip. Soda lime, a CO2
absorbent (Wako Chemicals, Japan) was added to the container and
the top was sealed with paraﬁlm and then dipped into liquid parafﬁn
to seal the container. The containers were inserted tip down into a
solution of eosin for color in a closed container at 25 °C and allowed to
equilibrate for 15 min. The movement of the liquid up the capillary
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calculated per ﬂy (on average 1 ﬂy weighs 0.80±0.11 mg (n=180)).
All ﬂies were measured at the same time and a respirometer without
ﬂies was also measured to correct for variations in ambient
temperature and pressure. Three to ten independent assays were
performed for each genotype in each condition. The mean value and
standard error of the replicates was calculated and the Student's t-test
was performed to check for signiﬁcant differences.
Homology prediction and interaction network
All homology predictions for candidate genes were made using
NCBI BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and STRING
version 8.2 (www.string-db.org). The network for the DGC interactors
was built by integrating obtained genetic interaction results to
publically available interaction data. STRING version 8.2 (www.
string-db.org) was used as the interaction data resource. The DGC-
interacting members were classiﬁed into functional groups based on
information obtained from FlyBase (http://ﬂybase.org/) for Drosophila
and the function of their orthologs. The associationwith disorders was
identiﬁed using the GeneCard Human Gene Database version 3
(http://genecards.bioinformatics.nl).
Results
Like in vertebrates, Drosophila Dystroglycan and Dystrophin are
expressed in adult muscles and their deﬁciencies cause age-dependent
muscle degeneration
Adult Drosophila multi-ﬁber muscles structurally resemble the
vertebrate striated muscles with a highly conserved basic patterning
consisting of actin (Z-band) and myosin (M-band) containingFig. 1. Drosophila DCG is localized to the sarcolemma. Transverse sections of Drosophila IFM a
Dg (A, E, I) and anti-Dys antibodies (B, F, J) (Dg, Dys—red and in separate channel, DAPI—gree
the cytoplasm with signiﬁcant enrichment close to the membrane (indicated by arrowheadsmyoﬁbrils (Miller, 1950). We analyzed the tissue speciﬁc expression
of Dys and Dg in several types of these multinucleated muscle cells:
indirect ﬂight muscles (IFM, Figs. 1A–H), leg (Figs. 1I–L), ovarian, gut
and heart muscles (Supplementary Fig. 1). Consistent with Dg being a
transmembrane protein, in Drosophila it is localized in the muscle
sarcolemma (Figs. 1A, E, I, Supplementary Fig. 1). A punctate staining is
seen in the regions that coincide with Z-bands, which resemble
costameric regions of myoﬁbril connections in vertebrates (Supple-
mentary Figs. S1G, O, T). The presence of Dg in these bands suggests
that it might connect Drosophilamyoﬁbrils to the extracellular matrix.
In Dg loss-of-function mutant DgO55/DgO86, Dystroglycan staining is
diminished (Figs. 1C, G, K, Supplementary Fig. 1). Dys is a cytoplasmic
protein that connects to Dg via its N-terminus and to cortical actin via
its C-terminal end. In Drosophila, the Dys protein is present in the
muscle cytoplasm, and transverse sections show that Dys is enriched
in close proximity to the sarcolemmawhere Dg is located (Figs. 1B, F, J,
Supplementary Fig. 1). Dystrophin staining is no longer detected in
DysDf loss-of-function mutant (Figs. 1D, H, L, Supplementary Fig. 1).
These data show the similarity of Dys and Dg localization inDrosophila
and invertebrate adult muscles (Cote et al., 2002; Ervasti, 2003)
implying that in different species these proteins may have analogous
roles.
Previously it has been shown that the Dys hypomorph and Dys and
Dg RNAi mutants exhibit age-dependant muscle weakening and loss,
climbing defects and reduced lifespan (Shcherbata et al., 2007; Taghli-
Lamallem et al., 2008), now we conﬁrmed the appearance of age-
dependentMD in Dg and Dys loss-of-function mutants (Supplementary
Fig. 2). Dystrophin mutants showed plenty of mildly degenerated
muscles, while the extreme muscle degeneration phenotype was
frequently seen in Dys and Dg old mutant ﬂies (Supplementary Fig. 2).
Mostly, myoﬁbrils on the periphery of the muscle were extensively
damaged (Supplementary Fig. 2H), the more central parts appeared tond leg muscles and longitudinal sections of trochanter (TDT) muscles stained with anti-
n). Dystroglycan is localized to the muscle membrane and Dystrophin staining is seen in
). Antibody staining is no longer seen in Dg (C, G, K) and Dys (D, H, L) mutant muscles.
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of mechanical stress and one function of the DGC is to provide
mechanical reinforcement to the sarcolemma, loss of Dys and Dg
compromises sarcolemma integrity causing focal muscle deterioration.
Thehealthymuscle cell actively regulates itsmetabolism,determinedby
substrate availability and energetic requirements. However, when
muscle cell performance is jeopardized, metabolism regulation is
disabled resulting in replacement of muscle by fatty and ﬁbrous tissue.
Since theprimesourceof energyduringmuscle contraction is fatty acids,
we tested ifDys andDgdeﬁciencies lead to improper consumption of fat.
Wedetected lipid droplets inDys andDgdeﬁcientmuscles; however the
amounts of intramuscular fatwere not obviously different in control and
mutant muscles (Supplementary Figs. 2L–M). Also they contained no
extra quantities of collagen visualized by aniline blue staining (data not
shown), instead, zones of abnormal muscle tissue showed signs of
necrosis marked by pale H&E staining (Supplementary Fig. 2I).Genetic modiﬁer screen for components that interact with Dys and Dg in
muscles
The DrosophilaMDmodel provides a unique possibility to screen for
DGC interactors that are not necessarily biochemically linked but act
transiently by testing for a trans-heterozygous interaction. Previously
performed large-scale primary screens identiﬁedmodulators of a wing-
vein phenotype in Dys and Dgmutants (Kucherenko et al., 2008). Now
we carried out the secondary screen to analyze if these modulators
would speciﬁcally modify Dys/Dg age-dependent muscular dystrophy.
When Dys and Dg are reduced by one copy (DysDf/+, Dg323/+ and
DgO86/+), no obvious changes in muscle morphology are observed
(Supplementary Table 3, Figs. 2A–B, F–G), therefore these mutants
were used to identify trans-heterozygous interactions. Importantly,
Dys/Dg trans-heterozygotes showed a genetic interaction, the occur-
rence of degenerated muscles signiﬁcantly increased (DysDf/DgO55
17.7%, n=69, DysDf/DgO86 19%, n=97, DysDf/Dg323 18%, n=44,
Figs. 2A–B, F, Supplementary Figs. 2H, J). Flies lacking one copy of
the gene-candidate in the Dys and/or Dg heterozygous background
were aged for three weeks and the frequency of degenerated muscles
was quantiﬁed (Figs. 2A–B, F, H–J, Supplementary Tables 3 and 4). In
addition, DysN-RNAi:act-Gal4 and DgRNAi:tub-Gal4 mutants showed a
moderate muscle degeneration (Figs. 2C–D, Supplementary Table 3),
which made them suitable for identifying dominant suppressors or
enhancers (Figs. 2C–D, K–L, Supplementary Table 3). To conﬁrm or
disprove found interactionswe usedmultiple alleles of the same gene;
to avoid an additive effect control crosses to the w1118 line were made
(Fig. 2E, Supplementary Tables 3 and 4). Some differences were
noticedwhen different alleleswere analyzed due to the diverse nature
of mutations that can cause possible incongruent effects on protein
structure and function, in turn causing a different pattern of
interaction. In totalwe found16modiﬁers ofDys and/orDg-dependent
muscle degeneration (Supplementary Table 3) that have been sorted
into ﬁve groups: (1) signal transduction and/or (2) cytoskeleton
organization, (3) regulation of gene expression, (4) metabolism, and
(5) genes with unknown function (Fig. 3A). Most interestingly many
genes from these different groups could be labeled as the stress
response genes that control cell adaptation to mechanical and cellular
stress and factors involved in neuro-muscle communications (Fig. 3B).
We identiﬁed Cam (Calmodulin), capt (capulet) and Lis-1 (Lissence-
phaly-1) as Dys-interacting components (Fig. 3A). Reduction of Cam
and capt by one copy showed heterozygous interaction with DysDf and
DysN-RNAi:act-Gal4 resulting in an increased frequency of muscle degen-
eration. Reduction of Lis-1 also led to a heterozygous interaction with
DysDf (~10–27%), and increased the DgO86 phenotype, but since Lis-1
heterozygotes also show some muscle degeneration, the Dg/Lis-1
phenotype (~5–8%) was considered as additive (Fig. 2B, Supplementary
Table 3).Fkbp13, Pgk (Phosphoglycerate kinase), SP2353 and vimar (visceral
mesoderm armadillo repeats) mutants showed strong interaction as
trans-heterozygotes with Dg, but not Dys and were considered as Dg
interacting components, vimar also strongly enhances the DgRNAi:tub-
Gal4muscle degeneration phenotype (Fig. 2D, Supplementary Table 3).
Nine other DGCmodiﬁers, Nrk (Neuronal receptor kinase), Fhos, ßν-
Integrin, robo (roundabout), chif (chiffon), mbl (muscleblind), Rack1
(Receptor of activated protein kinase C 1), CG7845 and CG34400
interacted with both Dys and Dg. They increased the frequency of
muscle degeneration of Dys and Dg loss-of-function heterozygous
mutants and, mostly, enhanced Dys and Dg RNAi phenotypes (Fig. 3A,
Supplementary Table 3). Intriguingly, reduction of robo by one copy
suppresses muscle degeneration in DysN-RNAi:act-Gal4 and DgRNAi:tub-
Gal4 mutants (Figs. 2C–D, Table S2). It has been shown that D.
melanogaster cardiac lumen formation is dependent on interactions
between the Slit/Robo pathway and Dg (Medioni et al., 2008) and the
loss of Dys leads to an age-dependent disruption of the myocardium
myoﬁbrillar organization and alterations in cardiac performance
(Taghli-Lamallem et al., 2008). Further studies of the DGC and Slit/
Robo interactions are valuable since muscular dystrophies in humans
cause progressive cardiomyocyte degeneration and ﬁbrosis.
Sincemany genes that showed interactionwith theDGC are notwell
characterized, we ﬁrst examined if they are evolutionarily conserved
and have homologs implicated in human diseases. Computational
analysis of protein identity showed that all of the found genes have
vertebrate homologs and many of them have a high degree of protein
similarity and identity (Fig. 3C, Table 1). Data analysis showed thatmost
of the vertebrate homologs could be classiﬁed by their association with
two disorders: muscular dystrophies and/or tumors (Table 1). These
ﬁndings are interesting due to the fact that the DGC is implicated not
only inMDdevelopment, but alsoDg is downregulated in awide variety
of tumors, with low levels of expression correlating with a poor
prognosis (Muschler et al., 2002).Most tumor cells, likemuscles, require
a large amount of glucose and are likely to be subjected to energetic
stress. Logically, both proteins involved inmetabolic processes, Pgk and
Vimar showed interactions with Dg only, suggesting that the low-
energy pathway may play a role in tumor progression and muscle
maintenance via Dg. This evidence provides good reason to study in
more detail the effect of energy metabolism on dystrophic muscles.
Novel genes found in the DGC modiﬁer screen have speciﬁc roles in
muscle function
Next, we tested if mutations in found genes would affect muscle
maintenance (Fig. 3, Table 1). Two of the genes found to interact with
Dys, Cam and capt did not show considerable muscle degeneration
when downregulated via RNAi driven by tub-Gal4, suggesting that
both proteins may affect muscle only via Dys. Mutations in another
Dys interactor Lis-1, both DGC-interacting genes that regulate gene
expression: mbl and chif, a formin homology protein Fhos, and a
transmembrane protein CG34400 showed a signiﬁcant frequency of
defects in ageingmuscles (Table 1, Figs. 4A, D–F). Consistent with the
Nrk gene being expressed speciﬁcally in the nervous system (Oishi
et al., 1997), downregulation of Nrk in motor neurons, but not in
muscles, affected muscle maintenance (Table 1, Figs. 4A, G). The
DGC-interacting mutants with unknown function: CG7845, vimar,
SP2353, Fkbp13 and non-DGC-interacting mutants: nAcRalpha and
SP1070 also showed signiﬁcant muscle deterioration (Table 1,
Figs. 3A, H–N).
Since it has been shown that high temperature stress causes
behavioral dysfunction and noticeably exaggerates muscle electrical
responses (Benshalom and Dagan, 1981; Montana and Littleton,
2004), we also tested if dystrophic muscle function is affected by
heating ﬂies (~39 °C) and calculated their mobility index. The high
temperature induced mobility defects seen with Dys mutants are
muchmore severe than those seenwith Dgmutants, nonetheless both
Fig. 2. In the genetic screen for components that genetically interact with Dys and Dg in muscle maintenance the frequency of muscle degeneration resulting from heterozygous
interaction between DysDf (A), DgO86 (B), Dg323 (F) and screened alleles was measured. (C, D) Modulation of DysN-RNAi:act-Gal4 and DgRNAi:tub-Gal4muscle degeneration phenotype
by one copy reduction of screened components. (E) The frequency of muscle degeneration phenotype by one copy reduction of screened components. Statistics were done using the
χ2-test with one degree of freedom and Yates's correction. Asterisks indicate statistically signiﬁcant (p≤0.05) heterozygous interactions (A, B, F), enhancement or suppression of
Dys and Dg RNAi phenotype (C, D), and dominant muscle degeneration phenotype in screened alleles (C). (H–L) Exemplary IFMs showing muscle degeneration from 3 weeks old
animals lacking Dys or Dg and one copy of screened alleles in comparison to DysDf/+ ﬂies (G).
233M.M. Kucherenko et al. / Developmental Biology 352 (2011) 228–242had a lower mobility index than wild type (Fig. 4B). In addition, under
high temperature stress the majority of the screened mutants also
have signiﬁcantly reduced mobility indices (Table 1, Fig. 3B), suggest-ing their possible involvement in muscle stress responsive pathways.
Since many of these genes have not been studied previously in
Drosophila, further experiments are planned.
Fig. 3. DGC-interacting components. (A) An interaction network for the DGC. Proteins are shown as nodes and the relationship as edges (edge color indicates evidence for
interaction). (B) Proportion of interacting factors divided into functional groups. (C) Homology of DGC-interacting components with vertebrates.
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Many genes found in ourmuscle screenhave been shownpreviously
to be involved in cellular adaptive responses. For example, βν-integrin,
Fhos, captandCG34400encode forproteins that bind to actin and control
muscle cell cytoskeleton rearrangement in response to mechanical
stress (Boehm et al., 2005; Gasteier et al., 2005; Mburu et al., 2003;
Medina et al., 2008; Perkins et al., 2010). Mechanical stress is translated
by the cell into biochemical signals such as changes in intracellular
calcium levels leading to activation of diverse signaling pathways.
Additionally, levels of Ca2+ can be regulated by Cam and FKBP13 and
abnormal Ca2+ homeostasis leads to oxidative stress (Bellinger et al.,
2009;Chakkalakal et al., 2006). TheDGC interactors, Pgk andVimarhave
been implicated in cellular homeostasis, and Rack1modulates response
to energetic stress (Qiu et al., 2010).
Since muscle is a highly sensitive tissue that responds to environ-
mental stresses in its patternofmetabolic activity and tissue integrity,we
decided to test ﬁrst how Drosophila normal muscles respond to stress:
suboptimal ambient temperatures, oxidative and energetic deﬁciency
stress.
To begin with we evaluated the frequency of muscle degeneration
in two control laboratory lines (OregonR and w1118) kept at differenttemperatures. Muscle maintenance was not affected in ﬂies residing
at 18 °C and 25 °C and any signiﬁcant difference was detected be-
tween these two groups. However, staying at higher temperature
(33 °C) led to muscle maintenance defects. Not only was the
frequency of muscle degeneration signiﬁcantly increased (~4 times
in comparison to 18 °C and 25 °C, Figs. 5A–D, Supplementary Table 5),
extreme muscle degeneration was also observed (Fig. 5A, black bars).
It has been shown that hyperthermia-induced muscle degeneration
is linked with oxidative stress (Mujahid et al., 2005). There is also
increasing evidence that oxidative stress, due to reactive oxygen species
(ROS) production overpowering the intracellular antioxidant systems,
causes muscle wasting both during ageing and in chronic pathological
states (Vercherat et al., 2009). Therefore we next attempted to amplify
oxidative stress by culturing ﬂies on food containing Paraquat, a
superoxide radical generating agent. The occurrence of degenerated
muscles was signiﬁcantly higher than under normal conditions
including extreme muscle degeneration (Figs. 5A, E–F, Supplementary
Table 5).
Unexpectedly, in ﬂies the frequency of abnormally maintained
muscles did not increase with age, implying that healthy muscles did
not show any dependence on animal's age (Fig. 5A, Supplementary
Table 5).
Table 1
Components implicated in muscle maintenance.
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Vertebrate homologs 
Function 
Cell adhesion, signaling  
Ca2+ -dependant pathways regulation, 
interaction with DGC components
Actin polymerization, signaling, cell 
polarity, cell motility, CAP2 found in 
developing striated muscles  
Actin cytoskeleton organization 
Unknown
Regulatory subunit of Cdc 7 kinase, DNA 
replication, cell cycle, integrin signaling  
Actin polymerization, MTs organization, 
signaling, muscle function regulation
Unknown
Actin polymerization, dynein binding, 
cellular macromolecule localization, 
microtubule-based movement 
Regulation of splicing, muscle 
differentiation, recruitment of integrin to 
focal adhesions 
Acetylcholine receptor, Ca 2+ transport, 
activation of MAPK 
Receptor for Agrin, MAPK signaling, 
transcription, protein phosphorylation, 
muscle development, function in NMJs 
Glycolytic enzyme, electron carrier activity, 
transferase activity, functions in glycolysis, 
function in NMJs
Signaling
Cytoskeleton rearrangement, axon guidance
receptor, ureteric bud development
Cell fate specification, aortic valve 
specification 
Dg ligand, photoreceptor ribbon synapse 
formation
GTP–GDP dissociation stimulator , 
regulation of mitochondrial function
Involvement in disorders 
–
Muscular dystrophy, 
cardiomyopathy, cancer  
Enhances muscular dystrophy 
in mice
Cancer, metastasis  
Deafness
Unknown
Cancer
Unknown
Unknown
Lissencephaly
Myotonic dystrophy  
Schizophrenia, cognitive 
defects
Congenital myasthenic 
syndrome  
Mental retardation, Menkes 
disease
Cancer
Multiple congenital 
abnormalities, vesicoureteral 
reflux
Aortic valve disease 
Congenital muscular 
dystrophy (AGRN)
Cancer
Genotype
Oregon R 
tub-Gal4/+
MHC-Gal4/+
D42-Gal4/+
βv-IntegrinBG01037
CamRNAi; tub-Gal4 
captRNAi; tub-Gal4
CG34400c07121/c05107
CG34400RNAi; tub-Gal4
CG7845RNAi; MHC-Gal4
chif EY05746/A507
chif EY05746/BG02820 
 chif BG02820/A507 
FhosA055 
FhosEY09842 
FhosA055/EY09842
Fkbp13RNAi; tub-Gal4
Lis-1RNAi; MHC-Gal4 
mblRNAi; MHC-Gal4 
NrkRNAi; MHC-Gal4 
NrkRNAi; D42-Gal4 
PgkRNAi; MHC-Gal4 
Rack1RNAi; MHC-Gal4 
roboRNAi; tub-Gal4 
SP1070UifE(br)155/+ 
SP1070Uif2B7/+
SP2353 RNAi; tub-Gal4 
SP2353f01290/c05961
vimar RNAi; MHC-Gal4 
% a
3.0 ± 3.0
0.8
2.4
4.0
0.0
7.8
32.0**
23.1**
20.0**
31.8**
22.6**
18.3**
46.7**
17.1**
24.3**
26.0**
12.0*
27.3**
16.1**
3.0
27.0**
4.4
4.8
34.0**
8.6
10.3
18.1**
21.1**
19.0**
30.7**
81.0**
n 
n = 98
n = 81
n = 42
n = 97
n = 10
n = 12
n = 50
n = 65
n = 70
n = 15
n = 53
n = 10
n = 30
n = 117
n = 14
n = 58
n = 10
n = 44
n = 62
n = 15
n = 18
n = 90
n = 84
n = 94
n = 85
n = 58
n = 10
n = 90
n = 21
n = 17
n = 32
Allele/+
Oregon R 
βv-IntegrinBG01037
Camn339
captE636
CG34400c05107
CG7845EMS-Mod4
chif BG02820
FhosA055
Fkbp13P962
NA
mblE27
NA
Nrkk14302
PgkKG07478
Rack1EY00128
robo2
NA
SP2353MB00605
vimarEY09646
Indexb
1.00 ± 0.14
1.31 ± 0.21
0.74 ± 0.52
0.51 ± 0.03**
0.96 ± 0.12
0.57 ± 0.04**
0.68 ± 0.29
0.86 ± 0.21
0.65 ± 0.10*
0.56 ± 0.04**
–
0.57 ± 0.04**
–
1.23 ± 0.76
0.66 ± 0.05*
0.61 ± 0.06*
–
0.67 ± 0.05*
0.48 ± 0.01**
n
n = 118
n = 46
n = 106
n = 41
n = 57
n = 50
n = 51
n = 65
n = 42 
n = 61 
n = 57 
–
–
n = 52 
n = 58
n = 40 
–
n = 37 
n = 37
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r
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e
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a Muscle degeneration frequency results were statistically compared using χ2 test with one degree of freedom and Yates's correction.
b Relative mobility results were statistically compared using t –test, *p≤0.05; **p≤0.01.
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Fig. 4.Mutations in DGCmodiﬁers result in muscle phenotypes. (A) Frequency of muscle degeneration in 3 week old mutant animals. Statistics were done using theχ2-test with one
degree of freedom and Yates`s correction. (B) Mutants exhibit dominant temperature-sensitive mobility defects. Statistics were done using the t-test. *p≤0.05; **p≤0.01. (C–N)
H&E-stained parafﬁn sections of exemplary IFMs, arrows indicate muscle degeneration.
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welfare (Fig. 5A, Supplementary Table 5). Normally when ﬂies are
glucose-deprived, they adapt by changing their metabolism from
glycolysis and glycogenolysis to lipolysis, which results in lower CO2
production. Control ﬂies lower their metabolic rate approximately 5
times as a reaction to change in food conditions measured here by the
amount of produced CO2 (Fig. 5G, Supplementary Table 6).
Adult Drosophila dystrophic muscles are more sensitive to stress
Nowweshowed that suboptimal conditionshave an effect onnormal
muscle maintenance in Drosophila. Dystrophic muscles, however, may
have a somewhat different response to stresses depending on the
structural differences of muscle cells as well as changes in metabolic
processes. To study the speciﬁcity of stress response in dystrophicmuscles we applied different stresses to Dys and Dgmutants. Because of
higher lethality ofDys andDgmutants under the stress in comparison to
control (OregonR) line, less amount of time was used to keep animals
under experimental conditions (Supplementary Table 5, experimental
groups 2 and 3).
As expected, high temperature and oxidative stress affectedmuscle
welfare in all tested animals, wild type and mutants (Fig. 6A,
Supplementary Table 5). Elevation of environmental temperature
from 25 °C to 33 °C about two times increased the incidence of
degenerated muscles in mutant animals, similarly to non-mutant. In
all analyzed lines, the calculated phenotype included 20–30% of cases
with extreme muscle degeneration (Fig. 6A, black bars, E–F, Supple-
mentary Table 5). Also on Paraquat-containing food the ratio or degree
of muscle degeneration was not increased in Dys and Dg mutants in
comparison to control (Fig. 6A, Supplementary Table 5), suggesting
Fig. 5. Oxidative and temperature stress cause muscle degeneration in wild type
Drosophila. (A) A bar graph shows frequency of muscle degeneration in OregonR and
w1118 ﬂies under inﬂuence of different conditions (temperature—18 °C, 25 °C, and 33 °C,
ageing, oxidative stress induced by feeding Paraquat and energetic stress induced by
sugar deﬁcit, NF - normal food). Frequency of severe muscle degeneration is
represented as black bars. Statistics were done using one-way ANOVA with post
Dunnett's tests, where data from different “experimental conditions” groups (light grey
box) were compared with control group (dark grey box). ** p≤0.01; ***p≤0.001. Black
stars show comparison of total muscle degeneration, while pink stars represent
comparison of extreme muscle degeneration. (B–F) Examples of OregonR IFMs at
different conditions. Arrows indicate degenerated muscles and arrowheads point to
muscles scored as extremely deteriorated. The metabolism response of wild type
animals to loss of energy source is shown in (G). Statistics were done using the t-test.
*** p≤0.001.
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degeneration in Drosophila, but muscle tissue in general is sensitive to
oxidative stress.
Unlike inwild typeanimals, exposureofDys andDgmutants to lower
temperature (18 °C) caused the appearance of severe progressive
degeneration, followed by focal muscle loss (Fig. 6A, C–D, Supplemen-
tary Table 5). The muscle metabolism is temperature dependent and
requires a coordinated system of metabolic control. Since Dys and Dg
mutantmuscles already are compromised, lowering the temperature in
addition would accelerate degenerative processes. At 25 °C the
frequency of muscle degeneration was the lowest, suggesting that
25 °C is an optimal temperature regime for dystrophic animals.
Interestingly, ageing appeared to cause muscle degeneration
exclusively in dystrophic animals. Even though Dys and Dg mutant
ageing animals both showed an increased number of myoﬁbrils with
moderately and extremely abnormal tissue structure, only mutation
in Dys gene signiﬁcantly ampliﬁed the amount of degenerated
muscles (Fig. 6A, Supplementary Fig. 2, and Supplementary Table 5).
Sugar-free food conditions promoted severe muscle loss only in
Dg mutants (Fig. 6A, black bar, G, Supplementary Table 5). Undernormal conditions OregonR ﬂies and Dys and Dg mutant animals
showed similar metabolic rates (2.20±0.15, 2.41±0.09, 2.36±0.18
respectively). Under glucose deprivation control ﬂies produced ﬁve
times less CO2 indicating that their metabolic activity went down as
expected (Fig. 6B). Dys mutants also signiﬁcantly slowed down their
metabolism; on sugar-free food they produced 2. 3 times less CO2
than on normal food (Fig. 6B, Supplementary Table 6), while Dg ﬂies
continued to produce a fair amount of CO2 (only 1. 6 times
reduction, Fig. 6B, Supplementary Table 6) implying that the
protective system required for lowering the metabolism in response
to energetic stress is malfunctioning when Dg is absent. The Dys
phenotype can be explained due to the fact that Dg localization is
diminished in the absence of Dys (data not shown). These data
suggest that Dg, but probably not Dys, plays a role in the pathway
required to maintain muscle integrity under energetic stress and
may be involved in the process of metabolic switch as an adaptive
response to sugar shortfall.
Dg is implicated in control of muscle cell metabolism
One of the newly found DGC interactors involved in control of
cellular metabolism is a phosphoglycerate kinase, PGK, an enzyme
required for ATP generation in the terminal stage of the glycolytic
pathway. Similar to the DGC, PGK has been localized in the Drosophila
ﬂight muscle cells to M-lines and Z-disks (Sullivan et al., 2003).
Drosophila Pgk mutants display reduced lifespan, abnormal mobility,
blocked synaptic transmission and heat-induced seizures (Wang
et al., 2004). Our data also show strong genetic interaction of PGKwith
Dg, but not with Dys (Figs. 7A, C–D), suggesting that Dg together with
PGK may have a role in regulation of cellular metabolism. To test this
we analyzed the frequency of muscle degeneration in double trans-
heterozygous mutants on sugar-free conditions. If PGK is involved in
the control of glycolysis, then upon sugar deﬁcit when animals transit
their metabolism from glycolysis to fatty acids oxidation, the Dg and
Pgk interaction should not be manifested. Indeed, on sugar-free food
Dg/Pgk trans-heterozygous mutants did not display a muscle
degeneration phenotype (Figs. 7A, E) showing that Dg has a role in
regulation of the glycolytic pathway. The function of glycolysis and
glycogenolysis in muscle is to provide ATP for myosin ATPase to
enable contraction. Decrease in ATP levels should lead to the lowering
of muscle contraction subsequently leading to abnormal motor
behavior. Neither Dg/+ nor Pgk/+ mutants showed signiﬁcantly
decreasedmobility upon heating (Table 1 for Pgk/+, Fig. 4B forDg/+);
however, Dg/Pgk heterozygotes signiﬁcantly lessened their ability to
move (Fig. 7B). Taken together these data show that Dg interacts with
Pgk, a component of the glycolytic pathway that is essential to sustain
energy for proper muscle functioning. This implies that Dg has a role
in cellular response to energetic crisis.
Discussion
The DGC deﬁciencies lead to muscle degeneration and malfunction
Within the past couple of years different animal models for DGC-
associated muscular dystrophy have signiﬁcantly contributed to
understanding the disease pathogenesis, but many questions about
the mechanisms of these disorders remain unanswered. Drosophila
has been shown to be an appropriate model to study the DGC since
nearly all its known components are present and are evolutionarily
conserved (Greener and Roberts, 2000), furthermore, mutations in its
components, Dystrophin, Dystroglycan and sarcoglycan cause age-
dependent progression of muscular dystrophy (Allikian et al., 2007;
Shcherbata et al., 2007; Taghli-Lamallem et al., 2008).
We ﬁrst show that like in vertebrates, Drosophila homologues of
Dys and Dg are expressed in muscles. In multinucleated muscle cells
Dg is present in the sarcolemma and is enriched around Z-bands that
Fig. 6. Dystrophic muscles respond differently than wild type to stress. (A) A bar graph shows frequency of muscle degeneration in OregonR ﬂies and Dys and Dg mutants under
inﬂuence of different conditions (temperature—18 °C, 25 °C, and 33 °C, oxidative and energetic stress, ageing). Black bars represent the frequency of extreme muscle degeneration.
Statistics were done using one-way ANOVAwith post Dunnett's tests. First, data for Dys andDgmutants were compared toOregonRwithin each “experimental conditions” group and
then data from different groups (light grey box) were compared with control group (dark grey box). *p≤0.05; **p≤0.01; ***p≤0.001. Black stars show comparison of total muscle
degeneration, while pink stars represent comparison of extreme muscle degeneration. (B) Bar graph shows fold decrease in metabolic rate in dystrophic animals and OregonR line in
response to loss of energy source. To determine the fold reduction in CO2 production the amount of CO2 generated under normal food conditions was divided by the amount of CO2
generated under sugar-free food conditions for each genotype tested. The average value is reported with the error bars representing the standard error. Statistics were determined
using a two-tailed Student's t-test, ***p≤0.001. (C–G) Exemplary Dys and Dg mutant IFMs at different conditions. Arrows indicate degenerated muscles and arrowheads point to
muscles scored as extremely deteriorated.
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Dys is enriched in the muscle cytoplasm adjacent to the sarcolemma.
Dys and Dg are also located postsynaptically in the larval NMJ, and
both are believed to be involved in retrograde signaling to the
presynapse (Bogdanik et al., 2008; van der Plas et al., 2006). Therefore
the DGC controls not only cellular homeostasis of the muscle cell but
also its ability to communicate with themotoneuron. Mutations in the
DGC affect both, muscle tissue maintenance leading to myodegenera-
tion and functioning causing heat-induced immobility.
Dys and Dg have different partners implying their involvement in
different signalling
Even though Dys and Dg are biochemically linked, mutations in
each of them cause partially distinct phenotypes, suggesting that they
may act with various components regulating diverse processes
required for maintaining muscle integrity. Dys mutants differ from
Dg mutants in their behavior; while the ﬁrst are not able to move, the
second jump chaotically (based on observations). It has been noted in
studies of the Drosophila larval NMJ that Dys and Dg mutants have
opposite phenotypes, Dg mutants have shown a decrease in quantal
content (Bogdanik et al., 2008), while Dys mutants have shown an
increase in quantal content with an increase in spontaneous
neurotransmitter release (van der Plas et al., 2006). When Dg was
down regulated at the larval NMJ Dys expression was no longer
localized (Bogdanik et al., 2008); however, when Dys was down
regulated, Dg was still localized but to a lesser extent. The absence of
Dg causes laminin to not be localized to the larval NMJ leading to
disorganization of active zones (Bogdanik et al., 2008; Jacobson et al.,
2001; Taniguchi et al., 2006; Tremblay and Carbonetto, 2006; van der
Plas et al., 2006). This could lead to a severely mis-functioning NMJ
that is not capable of transmitting a signal to the muscle to lead to atemperature-sensitive phenotype. Conversely, when Dys is absent,
there is still the organization of the NMJ to lead to neurotransmission,
but ultimately causing a failure of the contractile apparatus of the
muscle possibly due to over excitation of neurotransmitter release.
Therefore, we can propose that heat-induced immobility in Dys
mutants is caused by improper retrograde signaling from muscle to
the neuron, which causes constant muscle hypercontraction and
subsequent degeneration of ﬂight muscles. In Dgmutants shortage in
NMJ functioning may cause faulty neurotransmission to the muscle
leading to a loss of insufﬁciently innervatedmuscle ﬁbers (manuscript
in preparation).
Ageing also differentially affects muscle morphology: Dysmutants
signiﬁcantly increased the number of degenerated muscles, while Dg
deﬁciency mainly promotes the severity of muscle deterioration. The
similarity of phenotypes in Dys and Dgmutants is likely explained by
the secondary destabilization of the entire DGC that results from
deﬁciency of only one member. The differences in phenotypes are
probably due to distinct roles of each protein, Dys being a cytosolic
scaffold protein connecting the actin cytoskeleton to the plasmalem-
ma, and a transmembrane Dg providing the link to the ECM.
Since both proteins may have different binding partners and be
involved in different signaling pathways, we screened for unknown
components that can inﬂuence Dys and Dg-dependent MD pheno-
types. Our in vivo genetic screen in ageing dystrophicmuscles revealed
that the process of dystrophic muscle pathogenesis is multifunctional
by nature, as is the DGC function. Dys and Dg genetically interact with
multiple proteins that are involved in regulation of cell signalling,
calcium homeostasis, cytoskeleton rearrangements, sarcolemma
stability, energetic and oxidative stress, and cell polarity. Almost half
of identiﬁed genes showed interaction with both proteins, and about
one quarter speciﬁcally interacted with Dys or Dg (Fig. 3B). In general,
all found interactors could be divided into three subgroups: genes that
Fig. 7. Dg interacts with the glycolytic enzyme Pgk. (A) A bar graph shows frequency of
muscle degeneration from genetic interaction of Pgk with Dys and Dg in 13-15d old
animals kept for 10 days at normal or sugar-free food conditions in comparison with
OregonR. Statistics were done using the χ2-test with one degree of freedom and Yates`s
correction. Percentage of degenerated muscles for PgkKG07478/DysDf on normal food was
1% (n=72), sugar-free 0.5% (n=56) and PgkKG07478/DgO86 on normal food 33.8%
(n=59), sugar-free food 10% (n=70), for OregonR control see Supplementary Fig. 5.
(B) A bar graph represents temperature-sensitive mobility defects in Pgk/Dys and Pgk/
Dg heterozygotes. Indexes for temperature-sensitive mobility in 1–5 day old animals is
1.23±0.76 (n=52) for PgkKG07478/+, 1.68±0.38 (n=58) p=0.236 for PgkKG07478/
DysDf and 0.57±0.08 (n=58) p=0.029 for PgkKG07478/DgO86. Statistics were done
using the t-test. *p≤0.05. (C–E) Exemplary IFMs showing muscle degeneration from
13–15 day old animals of the genotypes PgkKG07478/DysDf and PgkKG07478/DgO86 kept at
normal (C–D) and sugar-free (E) food.
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genes that control neuron–muscle communication.
Muscle homeostasis depends not only on the cell autonomous DGC
function, but also on neuron–muscle communication
Interestingly 4 out of 16 interactors (Nrk, Pgk, FKBP13 and SP2353)
that have been found in our screen in ageing dystrophic muscles are
supposedly involved in NMJ function and all of them, except for Nrk,
genetically interact with Dg only. Disrupted glycosylation of α-DG in
humans results in congenital muscular dystrophies that are associated
with both progressive muscle degeneration and abnormal neuronal
migration in the brain (Collins and Bonnemann, 2010). Disorders with
the defects in NMJ transmission (congenital myasthenic syndromes,
CMSs) also lead to muscle weakness (Massoulie and Millard, 2009).
Drosophila Nrk (neurospeciﬁc receptor kinase) is highly homologous
(60% identity) to human MuSK (muscle receptor kinase), which is
essential for establishment and maintenance of the NMJs (Meriggioli
and Sanders, 2009). Activation of MuSK by binding to agrin leads to
clustering of acetylcholine receptors on the postsynaptic side of the
NMJ (Stiegler et al., 2009). Furthermore, it is known that agrin and
Laminin B can directly interact with dystroglycan and both of these
ligands have been shown to be involved in CMS development (Huze
et al., 2009). We also found in the screen Drosophila SP2353, a novel
agrin-like protein that contains a Laminin G domain, which makes it a
potential new extracellular binding partner for Dystroglycan. Thehuman ortholog for SP2353 (AGRN) is involved in congenital MD
development and the mouse homolog, pikachurin has been shown to
bind Dg in photoreceptor ribbon synapses (Huze et al., 2009; Sato
et al., 2008). Supposedly, dystroglycan and MuSK (Nrk) could be two
receptors and SP2353 a ligand important for transferring signals
necessary for normal NMJ function. However, whether these path-
ways share the same ligand components to provide neuron–muscle
communication has to be studied further.
FKBP13 is not extensively analyzed, however another member of
the FK506 binding protein family, FKBP12 is believed to be important
in regulating Ca2+ release through all ryanodine-receptor isoforms
and the 1,4,5-inositoltriphosphate receptors. Recently it has been
reported that FKBP12 is part of a macromolecular complex with RyR1
in mouse skeletal muscle. In mdx mice the associate of FKBP12 with
RyR1 is reduced leading to sarcoplasmic calcium leakage (Bellinger
et al., 2009). This dissociation is caused by increased RyR1 S-
nitrosylation via inducible NOS (iNOS), which is up-regulated in
dystrophic mouse (Bellinger et al., 2009). The DGC binds to neuronal
NOS (nNOS) via α-syntrophin, where nNOS is the principle source of
nitric oxide in skeletal muscle. When the DGC is disrupted via loss of
dystrophin nNOS is downregulated and a compensatory mechanism
causes the upregulation of iNOS, and consequently destabilization of
RyR1 due to nitrosative stress.
The DGC may act as a sensor in the mechanical stress response pathway
Muscle mechanosensitivity modulates diverse cellular functions
that ensure structural stability of muscle tissue in response to
mechanical stresses. There is an interesting group of the genes,
identiﬁed from our screen that play an important role in the assembly
of the actin cytoskeleton architecture and signal transfer to cause
cytoskeleton reconstruction. Dystrophic muscle stability is jeopar-
dized upon mechanical stress (Petrof, 1998), which suggests mis-
regulation of proteins that control cellular response to extracellular
mechanics. This implies that the DGC can act as a mechanosensoring
unit that transduces physical forces into biochemical information.
Actin cytoskeleton reorganization in response to mechanical
tension is controlled via different signaling pathways and, interest-
ingly Dys interactors Capt and Lis-1 are involved in this process
(Moriyama and Yahara, 2002; Wynshaw-Boris, 2007). Capt (cyclase-
associated protein) is a Drosophila homologue of human CAP1
(Table 1), which has been shown to play a key role in speeding up
the turnover of actin ﬁlaments by effectively recycling coﬁlin and
actin through its effect on both ends of actin ﬁlaments (Moriyama and
Yahara, 2002). CAP1 has coﬁlin- and actin-binding domains, which
makes it an attractive component to be involved in signal transduc-
tion and thereby links the cell signaling with actin polymerization.
LIS1 is associated with Miller–Dieker (classical lissencephaly) syn-
drome; it interacts with the actin cytoskeleton and dynein activity
(Gil-Krzewska et al., 2010; Wynshaw-Boris, 2007).
Found DGC interactor, RACK1 binds activated protein kinase C
(aPKC) and anchors it to the cytoskeleton. It has not been shown yet
that the Drosophila Rack1 gene can bind to aPKC, but it is 76%
homologues to the mammalian Rack1 proteins (Table 1). In mouse
skeletal muscle aPKC α associates with Annexin VI (Schmitz-Peiffer
et al., 1998), which provides a possible structural link for Rack1 to the
DGC through the hypothesized binding of Annexins to the TRPC
channels TRPC1 and TRPC4 that bind with α-syntrophin (Sabourin
et al., 2009). Rack1 also has a pro-apoptotic function by blocking Src
activation of the Akt cell survival pathway (Mamidipudi and Cart-
wright, 2009). There has also been suggested a role for the DGC in
inhibiting apoptosis by laminin binding toαDgwhich in turn activates
the PI3K/Akt pathway (Langenbach and Rando, 2002).
An additional cytoskeleton-controlling mutant identiﬁed from the
screen that exhibits muscle degeneration and temperature-sensitive
mobility defects is Fhos. A microarray screen identiﬁed an up-
240 M.M. Kucherenko et al. / Developmental Biology 352 (2011) 228–242regulated Fhos transcript in Drosophila Mhc mutants and further in
situ analysis revealed strong expression of Fhos in somatic muscles
and putative midline mesodermal cell (Montana and Littleton, 2006).
Fhos encodes for the protein homologues to human FHOD1 (a formin
homology containing protein). Formins are conserved in eukaryotes
from yeasts to mammals; they control cell polarity during processes
such as motility, cytokinesis, and differentiation by organizing the
actin cytoskeleton and microtubules (MTs) (Gasteier et al., 2005).
Recently a direct interaction between dystrophin and MTs has been
identiﬁed (Prins et al., 2009). This proposes that the DGC and Fhos
may act as a team in the MT organizing procedure.
Since skeletal muscle basal lamina is linked to the sarcolemma
through transmembrane receptors, including integrins and dystro-
glycan, it is plausible that their function may be somewhat redundant.
It had previously been shown that upregulation of integrin α7 in the
mdx background could ameliorate aspects of muscular dystrophy
(Burkin et al., 2001). However, when functional dystrophin is absent,
upregulation of integrin α7 could only compensate in mediating cell-
extracellular matrix attachment but cannot rescue the dystrophic
phenotype (Cote et al., 2002). In addition, in Drosophila, integrin-
mediated adhesion maintains sarcomeric integrity (Perkins et al.,
2010). Our ﬁnding that one of the Drosophila integrins interacts with
both Dys and Dg implies that the DGC is linked to the integrin
signaling pathway and further studies of different components of the
pathway may help to ﬁnd a way how to strengthen the plasma
membrane in dystrophic muscles. Additionally, mammalian homo-
logs formbl and chif, MBNL1 and DBF4 found in our screen have been
implicated in integrin signaling (Chen et al., 2009; Vicente et al.,
2007).
Since defects in mechanotransduction are linked with the
development of various diseases, ranging from muscular dystrophies
to cancer progression and metastasis, understanding the roles of the
DGC and its interacting proteins in mechanical stress response is very
important.
Stress inﬂuences the speed and the onset of muscle degeneration as
dystrophic muscles have abnormal cellular metabolism
Although the genetic basis of many dystrophies is known, the
exact processes by which muscles become progressively nonfunc-
tional remain a mystery. Since genes found in our screen have been
previously associated with cellular adaptive responses to stress, we
ﬁrst analyzed and compared the normal and dystrophic muscle stress
responsiveness using different stress conditions. Our data show that
muscle degeneration can be induced by stress. Furthermore, stress
accelerates the onset and severity of age-dependent muscular
dystrophy in Dys and Dg mutants. Normal and dystrophic muscles
are similarly sensitive to elevated temperature and oxidative stress.
Remarkably, cooler temperature ampliﬁed dystrophic muscle damage
comparable to what was seen in aged mutant animals. Energetic
stress had a large impact on the muscle structure of Dgmutants with
severe muscle degeneration far exceeding that observed in Dys
mutants. This ﬁnding is supported by previous studies, which also
showed association of Dg with energy homeostasis (Mirouse et al.,
2009; Takeuchi et al., 2009).
The muscle is the largest organ in the body that is required not only
formovement, but also for heat production and cold tolerance, playing a
crucial role in the overall energy balance. Calmodulin that plays a role in
the oxidative stress response pathway, is an expected DGC interactor,
since it binds to syntrophin (a component of the DGC) and CaM
dependent kinase is involved in phosphorylation of dystrophin and
syntrophin (Madhavan and Jarrett, 1999). In addition, the selective
oxidationor nitrationof CaM that occurs in vivoduring ageingandunder
conditions of oxidative stress modulates signal transduction processes
and intracellular energy metabolism (Squier, 2001). Additionally, the
Ca2+-buffering capacity of dystrophic muscles by Calmodulin andCalsequestrin also seems tobe impaireddue to a decrease in the levels of
these proteins (Pertille et al., 2010); and targeted inhibition of CAM
signaling worsens the dystrophic phenotype in mdx mouse muscle
(Chakkalakal et al., 2006). Importantly, reduction of Cam by one copy,
found as aDys interactor in our screen rescues theDys hypercontraction
phenotype (manuscript in preparation).
Also we have determined here that in muscles Dg, but not Dys is
required under conditions of energetic stress and both proteins
involved in metabolic processes, PGK and Vimar, showed interactions
with Dg only. Based on prior screen data, Vimar has been shown to
regulate mitochondrial function via an increase in citrate synthase
activity (Chen et al., 2008). Citrate synthase deﬁciency leads to a
decrease in ATP levels consistent with disruption of mitochondrial
energy production (Fergestad et al., 2006). Possibly, the involvement
Vimar has with the muscular dystrophy phenotype could be due to its
role inmitochondrial regulation. PGK is essential for the breakdown of
glycogen, resulting in the release of energy (Das et al., 2010; Wang
et al., 2004). In order to contract muscle cells needs ATP for myosin
ATPase, which can be provided either via the glycolytic pathway or by
mitochondrial oxidative phosphorylation. In Drosophila, a substantial
fraction of the ATP for ﬂight muscle contraction is provided through
the glycolytic pathway (Leopold and Perrimon, 2007; Sullivan et al.,
2003). In IFMs, glycolytic enzymes, including Pgk, are co-localized
along sarcomeres at M-lines and Z-discs and this co-localization is
required for normal muscle function (Sullivan et al., 2003; Wojtas
et al., 1997). Similarly to Dg mutants, Drosophila Pgk mutants display
reduced lifespan, abnormal motor behavior, altered synaptic struc-
ture, defective neurotransmitter release, and temperature-sensitive
seizures (Wang et al., 2004). Pgk deﬁciency in humans is a rare
inherited metabolic disorder sometimes associated with myopathies
(Das et al., 2010) and it would be thought-provoking to study in more
detail the effect of energy metabolism on dystrophic muscles.
Taken together our data demonstrate that the DGC is involved in
the muscle stress response pathway. Understanding the differences
between healthy and dystrophic adaptive reactions can lead to new
approaches for dystrophic muscle metabolism manipulation to
prevent progressive muscle loss. Further analysis of found Dys and
Dg speciﬁc interactions will allow for new opportunities for easier
drug targets in muscular dystrophy therapeutics and a better
understanding of muscular dystrophy dynamics.Acknowledgments
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